Literature DB >> 19437135

Detection of responsible mutations for beta thalassemia in the Kermanshah Province of Iran using PCR-based techniques.

Zohreh Rahimi1, Adriana Muniz, Abbas Parsian.   

Abstract

Beta Thalassemia has been reported to be a common genetic disorder in Iran. To establish the molecular spectrum of the beta thalassemias in the Kermanshah Province of Iran, 185 unrelated beta thalassemia patients with Kurdish ethnic background were studied (181 beta-thalassemia major and 4 beta-thalassemia intermedia). Using polymerase chain reaction-amplification refractory mutation system (PCR-ARMS), restriction fragment length polymorphism (RFLP) and direct genomic sequencing twenty different mutations were identified accounting for 98.1% of the alleles. Approximately 80.8% of beta-thalassemia chromosomes had beta(0) mutation. The most prevalent mutation was the IVSII-1 (G-->A) (32.97%), followed by CD8/9 +G (13.51%), IVSI-110 (C-->T) (8.38%), CD 36/37 -T (7.84%), CD8 -AA (5.94%), CD15 (G-->A) (4.86%) and IVSI-1 (G-->A) (4.59%). All of these mutations accounted for 78.1% of the alleles. The results described here will be of valuable help in the development of successful prevention programs for the population of Kermanshah.

Entities:  

Mesh:

Year:  2009        PMID: 19437135     DOI: 10.1007/s11033-009-9560-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  21 in total

1.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

2.  Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran.

Authors:  N Ghotbi; T Tsukatani
Journal:  East Mediterr Health J       Date:  2005-05       Impact factor: 1.628

3.  An unusually frequent beta-thalassemia mutation in an Iranian Province.

Authors:  Peyman Eshghi; Azita Zadeh-Vakili; Armin Rashidi; Ebrahim Miri-Moghaddam; Ebrahim Miri-Moghadam
Journal:  Hemoglobin       Date:  2008       Impact factor: 0.849

4.  Spectrum of beta-thalassemia mutations in Oman.

Authors:  S Daar; H M Hussein; T Merghoub; R Krishnamoorthy
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

5.  Molecular analyses of beta-thalassemia in Iran.

Authors:  G Nozari; S Rahbar; A Golshaiyzan; S Rahmanzadeh
Journal:  Hemoglobin       Date:  1995       Impact factor: 0.849

6.  The beta-thalassemia mutation spectrum in the Iranian population.

Authors:  H Najmabadi; R Karimi-Nejad; S Sahebjam; F Pourfarzad; S Teimourian; F Sahebjam; N Amirizadeh; M H Karimi-Nejad
Journal:  Hemoglobin       Date:  2001-08       Impact factor: 0.849

7.  Beta-thalassemia mutations and haplotype analysis in Lebanon.

Authors:  L Zahed; M Qatanani; M Nabulsi; A Taher
Journal:  Hemoglobin       Date:  2000-11       Impact factor: 0.849

8.  Molecular defects in beta-thalassaemias in the population of Saudi Arabia.

Authors:  M A el-Hazmi; A R al-Swailem; A S Warsy
Journal:  Hum Hered       Date:  1995 Sep-Oct       Impact factor: 0.444

9.  Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs.

Authors:  A D Adekile; L H Gu; E Baysal; M Z Haider; L al-Fuzae; K C Aboobacker; A al-Rashied; T H Huisman
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

10.  Identification of beta thalassemia mutations in South Brazilians.

Authors:  Vivian C D Reichert; Simone M de Castro; Sandrine C Wagner; Dulcinéia M de Albuquerque; Mara H Hutz; Sandra Leistner-Segal
Journal:  Ann Hematol       Date:  2007-12-11       Impact factor: 3.673

View more
  8 in total

1.  Thrombophilic mutations and susceptibility to preeclampsia in Western Iran.

Authors:  Shohreh Malek-Khosravi; Zohreh Rahimi; Ziba Rahimi; Faranak Jalilvand; Abbas Parsian
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

2.  Analysis of β/α globin ratio by using relative qRT-PCR for diagnosis of beta-thalassemia carriers.

Authors:  Reza Ranjbaran; Mohammad Ali Okhovat; Arash Mobarhanfard; Farzaneh Aboualizadeh; Mozhdeh Abbasi; Leili Moezzi; Habib Allah Golafshan; Abbas Behzad-Behbahani; Mandana Bagheri; Sedigheh Sharifzadeh
Journal:  J Clin Lab Anal       Date:  2013-07       Impact factor: 2.352

3.  Plasma lipids and lipoproteins in children and young adults with major β-thalassemia from western Iran: influence of genotype.

Authors:  Hamid Madani; Zohreh Rahimi; Mohammad Manavi-Shad; Hadi Mozafari; Reza Akramipour; Asad Vaisi-Raygani; Mansour Rezaei; Shohreh Malek-Khosravi; Ebrahim Shakiba; Abbas Parsian
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

Review 4.  Genetic epidemiology of hemoglobinopathies among Iraqi Kurds.

Authors:  Nasir Al-Allawi; Sarah Al Allawi; Sana D Jalal
Journal:  J Community Genet       Date:  2020-11-22

Review 5.  Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran.

Authors:  Zohreh Rahimi
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

6.  Molecular Characterization and Disease-Related Morbidities of β-Thalassemia Patients from the Northeastern Part of Iraq.

Authors:  Shaema Amin; Sana Jalal; Kosar Ali; Luqman Rasool; Tara Osman; Omed Ali; Abdalhamid M-Saeed
Journal:  Int J Gen Med       Date:  2020-12-09

7.  The prevalence of anemia and hemoglobinopathies in the hematologic clinics of the kermanshah province, Western iran.

Authors:  Mehrdad Payandeh; Zohreh Rahimi; Mohammad Erfan Zare; Atefeh Nasir Kansestani; Farzad Gohardehi; Amir Hossein Hashemian
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

Review 8.  Hemoglobinopathies in Iran: An Updated Review.

Authors:  Abolfazl Nasiri; Zohreh Rahimi; Asad Vaisi-Raygani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.